vs
Side-by-side financial comparison of Air Products (APD) and DaVita (DVA). Click either name above to swap in a different company.
DaVita is the larger business by last-quarter revenue ($3.6B vs $3.2B, roughly 1.1× Air Products). Air Products runs the higher net margin — 22.9% vs 6.5%, a 16.4% gap on every dollar of revenue. On growth, DaVita posted the faster year-over-year revenue change (12.3% vs 8.8%). Over the past eight quarters, DaVita's revenue compounded faster (6.6% CAGR vs 3.1%).
Air Products and Chemicals, Inc. provides atmospheric gases, process and specialty gases, equipment, and services worldwide. The company produces atmospheric gases, including oxygen, nitrogen, and argon; process gases, such as hydrogen, helium, carbon dioxide, carbon monoxide, syngas; specialty gases; and equipment for the production or processing of gases comprising air separation units and non-cryogenic generators for customers in various industries, including refining, chemical, gasificati...
DaVita Inc. is an American company that provides kidney dialysis services through a network of 2,675 outpatient centers in the United States, serving 200,800 patients, and 367 outpatient centers in 11 other countries serving 49,400 patients. The company primarily treats end-stage renal disease (ESRD), which requires patients to undergo kidney dialysis, often 3 times per week for the rest of their lives unless they receive a kidney transplant via organ donation.
APD vs DVA — Head-to-Head
Income Statement — Q2 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $3.2B | $3.6B |
| Net Profit | $724.8M | $234.2M |
| Gross Margin | 31.1% | — |
| Operating Margin | — | 15.5% |
| Net Margin | 22.9% | 6.5% |
| Revenue YoY | 8.8% | 12.3% |
| Net Profit YoY | 166.6% | 43.8% |
| EPS (diluted) | $3.19 | $3.22 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $3.2B | $3.6B | ||
| Q4 25 | $3.1B | $3.6B | ||
| Q3 25 | $3.2B | $3.4B | ||
| Q2 25 | $3.0B | $3.4B | ||
| Q1 25 | $2.9B | $3.2B | ||
| Q4 24 | $2.9B | $3.3B | ||
| Q3 24 | $3.2B | $3.3B | ||
| Q2 24 | $3.0B | $3.2B |
| Q1 26 | $724.8M | $234.2M | ||
| Q4 25 | $678.2M | $234.2M | ||
| Q3 25 | $4.9M | $150.3M | ||
| Q2 25 | $713.8M | $199.3M | ||
| Q1 25 | $-1.7B | $162.9M | ||
| Q4 24 | $617.4M | $259.3M | ||
| Q3 24 | $1.9B | $214.7M | ||
| Q2 24 | $696.6M | $222.7M |
| Q1 26 | 31.1% | — | ||
| Q4 25 | 32.1% | — | ||
| Q3 25 | 32.3% | — | ||
| Q2 25 | 32.5% | — | ||
| Q1 25 | 29.6% | — | ||
| Q4 24 | 31.2% | — | ||
| Q3 24 | 34.0% | — | ||
| Q2 24 | 32.8% | — |
| Q1 26 | — | 15.5% | ||
| Q4 25 | 23.7% | 15.5% | ||
| Q3 25 | 0.5% | 14.8% | ||
| Q2 25 | 26.2% | 15.9% | ||
| Q1 25 | -79.8% | 13.6% | ||
| Q4 24 | 22.0% | 17.2% | ||
| Q3 24 | 76.1% | 16.4% | ||
| Q2 24 | 24.7% | 15.9% |
| Q1 26 | 22.9% | 6.5% | ||
| Q4 25 | 21.9% | 6.5% | ||
| Q3 25 | 0.2% | 4.4% | ||
| Q2 25 | 23.6% | 5.9% | ||
| Q1 25 | -59.3% | 5.1% | ||
| Q4 24 | 21.1% | 7.9% | ||
| Q3 24 | 61.2% | 6.6% | ||
| Q2 24 | 23.3% | 7.0% |
| Q1 26 | $3.19 | $3.22 | ||
| Q4 25 | $3.04 | $3.22 | ||
| Q3 25 | $0.03 | $2.04 | ||
| Q2 25 | $3.20 | $2.58 | ||
| Q1 25 | $-7.77 | $2.00 | ||
| Q4 24 | $2.77 | $3.08 | ||
| Q3 24 | $8.75 | $2.50 | ||
| Q2 24 | $3.13 | $2.50 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $700.7M |
| Total DebtLower is stronger | $17.4M | $10.2B |
| Stockholders' EquityBook value | $18.1M | $-651.1M |
| Total Assets | $41.6M | $17.5B |
| Debt / EquityLower = less leverage | 0.96× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $700.7M | ||
| Q4 25 | $1.0B | $700.7M | ||
| Q3 25 | $1.9B | $736.5M | ||
| Q2 25 | $2.3B | $739.4M | ||
| Q1 25 | $1.6B | $511.9M | ||
| Q4 24 | $2.0B | $846.0M | ||
| Q3 24 | $3.0B | $1.1B | ||
| Q2 24 | $2.4B | $437.2M |
| Q1 26 | $17.4M | $10.2B | ||
| Q4 25 | — | $10.2B | ||
| Q3 25 | — | $10.2B | ||
| Q2 25 | — | $10.1B | ||
| Q1 25 | — | $9.6B | ||
| Q4 24 | — | $9.2B | ||
| Q3 24 | — | $9.3B | ||
| Q2 24 | — | $8.5B |
| Q1 26 | $18.1M | $-651.1M | ||
| Q4 25 | $15.4B | $-651.1M | ||
| Q3 25 | $15.0B | $-571.9M | ||
| Q2 25 | $15.5B | $-369.6M | ||
| Q1 25 | $14.7B | $-267.1M | ||
| Q4 24 | $16.7B | $121.1M | ||
| Q3 24 | $17.0B | $386.7M | ||
| Q2 24 | $15.1B | $632.9M |
| Q1 26 | $41.6M | $17.5B | ||
| Q4 25 | $41.2B | $17.5B | ||
| Q3 25 | $41.1B | $17.6B | ||
| Q2 25 | $41.7B | $17.5B | ||
| Q1 25 | $38.9B | $17.1B | ||
| Q4 24 | $40.0B | $17.3B | ||
| Q3 24 | $39.6B | $17.5B | ||
| Q2 24 | $37.0B | $17.0B |
| Q1 26 | 0.96× | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 75.76× | ||
| Q3 24 | — | 23.95× | ||
| Q2 24 | — | 13.35× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
